Autophagy is a very tightly regulated process that is important in many cellular processes including development, differentiation, survival, and homeostasis. The importance of this process has already been proven in numerous common diseases such as cancer and neurodegenerative disorders. Emerging data indicate that autophagy plays an important role in some liver disease including liver injury induced by ischemia reperfusion and alpha-1 antitrypsin Z allele dependent liver disease.
Introduction
Chronic viral hepatitis infection represents a major public health problem worldwide (1, 2) . It can be caused by several viruses, the most widespread being hepatitis B and C viruses (HBV and HCV, respectively) (3) . Hepatitis B and C may cause chronic liver infection that can lead to liver fibrosis and ultimately develop to liver cirrhosis and primary liver cancer. Current understanding of these infections has been advanced by studies of the mechanisms of liver fibrosis . Fibrosis was considered a progressive linear event but clinical evidence now suggests that fibrosis progression does not always have a fixed speed, but instead can have slower or rapid phases (4) . We have recently shown a direct link between autophagy and fibrosis in different systems ( 
Ghavami and Halayko unpublished data) including in different viral infections (5-7).
Here we focus on and review the importance of autophagy in viral hepatitis B and C infection and discuss some future possible targets for viral hepatitis B and C therapeutic strategies.
Epidemiology of HBV and HCV in the world
At the beginning of the third millennium, HBV infection poses a great burden on health systems around the world (8, 9) , 350-400 million suffering from this infection (10). It has been identified as one of the most important causes of liver failure and hepatocellular carcinoma (HCC) (11) . HBV can be transmitted parenterally by percutaneous and mucous membrane exposures to infected blood, sexual contact or perinatal exposure (12, 13) .
The World Health Organization (WHO) has compared hepatitis C virus (HCV) to a "viral time bomb" and estimates that about 180 million people (around 3% of the world's population) are infected with HCV, 130 million of whom are chronic carriers at risk of developing liver cirrhosis and liver cancer (14) . The main risk factors for HCV infection are blood and blood product transfusion, intravenous drug use, unsafe injections, tattooing and poor instrument disinfection by barbers, and rarely sexual contact. Haemodialysis, thalassaemia and haemophilia patients are at higher risk of HCV infection (9, 15, 16) .
Natural history and progression of HBV and HCV to cirrhosis and HCC
Hepatitis B virus infection has two presentations; acute, which occurs less than 6 months after acquiring the infection and is symptomatic, and the chronic phase of infection, which occurs more than 6 months after initial infection. HBV infection can be divided temporally into different stages after initial acquisition. The first stage is characterized as immune-tolerance (17) . In the second phase, the immune response becomes active and leads to cytokine release and cell lysis and an inflammatory infiltrate accumulates (10). The progression of HBV infection and the evolution of the various phases depends on host genetic factors and molecular characteristics of HBV such as genotype and presence of viral mutations (18) .
The natural history of HCV infection is totally different from HBV infection.
Approximately 20% of individuals spontaneously clear the infection. Again there are viral and host factors that determine HCV clearance or persistence (19) . Host genetic variation has been shown to contribute to the heterogeneity in HCV clearance and rate of response to antiviral therapy (20, 21) . About 30% of individuals with persistent infection develop chronic liver disease, such as cirrhosis and hepatocellular carcinoma (22) .
HBV and HCV classification and structure

HBV
Classification and Structure
HBV belongs to the Hepadnaviridae family. These viruses are characterized by having a partial double-stranded DNA genome, with numerous overlapping genes in multiple reading frames, which is copied through an RNA intermediate by a reverse transcriptase enzyme. HBV infects primarily hepatocytes. For more complete reviews, see (23) (24) (25) . The HBV, also known as the Dane particle, is approximately 45nm in diameter. The HBV genome is a circular DNA molecule of approximately 3200 nucleotides (Fig. 1A ) that encodes 3 different-sized envelope proteins (HBsAg) as well as several other structural and non-structural proteins (Fig. 1B, Table 1 ). At least one of the non-structural proteins (HBx) has been suggested to have a role in autophagy. Tang and colleagues found that HBx was involved in up-regulation of beclin-1 expression during starvation-induced autophagy (26) . Sir and colleagues demonstrated that HBV infection induced early autophagy in the absence of autophagic protein degradation, that autophagy enhanced HBV replication and that this was mediated by interaction between HBx and PI3KC3 to enhance the latter's activity (27) 
HCV
Classification and Structure
HCV belongs to the Hepacivirus genus in the Flaviviridae family. Flaviviruses have single-stranded, plus-sense (+) RNA genomes. The ~ 9.6kb genome acts directly as mRNA and all viral structural proteins as well as six non-structural proteins (NSP) are produced from a ~ 3000aa polyprotein precursor by viral and cellular proteases ( Fig.   2A ). The genome is encased by a nucleocapsid made from multiple copies of a single capsid (C) protein, which is surrounded in turn by a host-derived lipid envelope (Fig.   2B ), that contains two viral-encoded proteins, called E1 and E2 (Table 2 ). Basic residues in the amino terminal portion of C protein are essential for genomic encapsidation (29) . The precise numbers of C proteins, and native virion nucleocapsid dimensions, are not yet known. For more complete reviews, see (24, 30, 31) . ER stress and induction of the host cell unfolded protein response (UPR) have been known to be involved in HCV-mediated autophagy (32) . Similar responses were found by Asselah and colleagues to occur in HCV-infected liver biopsies (33) . Guevin and colleagues reported that the viral non-structural protein NSP5B, the viral RNA-dependent RNA polymerase (Table 2) , interacts with host proteins required for autophagy induction (6), and Ke and colleagues presented data that suggest UPR induction and formation of autophagic vacuoles was induced by HCV replication (34). Thus, as described in more detail in later sections, both HBV and HCV encode proteins that induce autophagy to the virus' benefit.
Over view of autophagy mechanism
Autophagy (Greek for "self-eating") refers to evolutionary conserved catabolic processes in which cytoplasmic macromolecules and organelles are degraded by lysosomes because they are damaged or they are needed as substrates to maintain energy homeostasis (35, 36) . Autophagy can be selective or non-selective with respect to the cytoplasmic component being degraded and targeted during this mechanism (37, (36, 39, 47) . With respect to infectious disease, some pathogens have evolved mechanisms to escape, inhibit or even exploit autophagy for their own benefit (36, 47) .
Apart from macro-autophagy, there are at least two other forms of autophagy.
One is chaperone-mediated autophagy (CMA) in which specific proteins containing a consensus peptide motif are translocated to the lysosome where binding to the lysosome-associated membrane protein type 2A (LAMP-2A) receptor is followed by protein internalization and degradation. The other is micro-autophagy in which cytosolic contents are internalized into lysosomes after direct invagination of the lysosomal membrane (35) .
In macro-autophagy (commonly, and in this review hereafter, referred to as autophagy), a portion of the cytoplasm becomes engulfed by an isolation membrane known as the phagophore (48). Through not fully understood mechanisms mediated by multiprotein complexes, a double-membrane structure (possibly derived from the ER, plasma membrane or mitochondria) called autophagosome is formed, the ends of which elongate until they fuse around the cargo (Fig. 3) (37, 49) . The autophagosome eventually fuses with the lysosome forming an autolysosome after which its contents are degraded by the lysosomal enzymes (50).
In yeast, more than 30 conserved autophagy-related genes (Atg) with several mammalian orthologs have been identified which are involved in the regulation of autophagy. One important pathway involves the mammalian target of rapamycin (mTOR) which negatively regulates a downstream complex of Atg1 (called ULK1 in mammals) Atg13 and FIP200 (39) (Fig. 3) . Activation of mTOR by class I Figure 3 . Summary of autophagy machinery in mammalian cells. Growth factors may inhibit autophagy via Akt activation while nutrient depletion induce this process via activation of adenosine mono phosphate protein kinase (AMPK) with subsequent inhibition of mTOR. Bcl-2 plays an important function in inhibiting autophagy by direct interaction with Beclin-1. After activation of the autophagy process, an autophagosome is formed which engulfs the cargo (e.g. damaged organelles). Two ubiquitine-like chain reactions involving Atg12-Atg5-Atg16 formation and LC3 I lipidation are involved in autophagosome double membrane formation. The autophagosome finally fuses with a lysosome forming an autophagolysosome and its content is subsequently digested by lysosomal enzymes. Besides the ULK1 complex, another factor implicated in initiation of autophagosome formation is the class III PI3K Vps34, the activity of which is enhanced by interaction with Beclin 1/Atg6 (51, 52) (Fig. 3) . Binding of Beclin 1 by the anti-apoptotic protein Bcl-2 inhibits autophagy (37).
The elongation of pre-autophagosomal structures involves two ubiquitine-like reactions, the first of which results in a complex between Atg12, Atg5 and Atg16 which is essential for the elongation (39) . The second is the microtubule-associated protein light chain 3 (LC3)-I (53). Following a reaction involving Atg7 and Atg3, LC3-I is converted to LC3-II, which is targeted to the elongating autophagosomal membrane (39, 53) . In contrast to the Atg12-Atg5-Atg16 complex, LC3-II remains bound to it until it has fused with the lysosome forming the autolysosome and LC3-II is commonly used to monitor autophagy (54, 55) . The contents of the autolysosome are degraded by proteases, lipases, nucleases, and glycosidases. Lysosomal permeases release the breakdown products into the cytosol for use in synthetic and metabolic pathways (56).
Virus and Autophagy
Many viruses are currently listed in the literature that are shown to induce autophagy.
Here we summarize some of the DNA and RNA encoding viruses that induce autopaghy.
DNA Viruses
Herpes Simplex virus1 (HSV1) and Human Cytomegalovirus virus (HCMV) are DNA encoding viruses that are members of the Herpesviridae family. Recently it was demonstrated that upon infection of human fibroblasts by these two viruses, early induction of autophagy with extensive lipidation of microtubule associated protein 1 light chain 3 (LC3) is promoted (57) . Another virus called Simian virus 40 that belongs to the family Polyomaviridae also enhances autophagy in HEK cells by inhibiting mTOR, and it is unclear whether autophagy induction by this virus enhances viral yield (58) .
RNA Viruses
Dengue virus, like HCV, belongs to the family Flaviviridae and it induces autophagy in vitro. Autolysomes formed upon Dengue virus infection are associated with helping viral replication and an increase in the viral yield (7, 59 ). Influenza A virus belongs to the family Orthomyxoviridae and its infection increases autophagy and autophagic flux through an unknown mechanism, and an increase in autophagy enhances viral replication and viral yield (59). Polio virus is with a member of the family Picornaviridae. 
Importance of autophagy in HBV and HCV infection and pathogenesis
As previously mentioned, autophagy is a key metabolic process that can eliminate unwanted, damaged and worn out constituents of the cells. However viruses use this process to modulate their replication in host cells. Some of the best examples of such viruses are HBV and HCV. Studying HCV and its role in pathogenesis of hepatitis is vital, and may lead to development of novel drugs that could be used for the treatment of viral hepatitis infected patients. There are reports in the literature that HCV induces autophagy in hepatocytes (5) . As was mentioned earlier, during autophagy, double membrane vesicles are formed known as autophagosomes. These autophagosomes fuse with lysosomes to form autolysosomes and degrade their contents. HCV induces incomplete autophagy via unfolded protein response pathway (32) . In these experimental studies, authors showed that HCV prevents the maturation of autophagosomes to autolysosomes so that the contents of the autophagosome are not degraded and HCV can use them for its replication (32) . This is one of the ways that HCV could possibly escape from the degradation by the autophagy pathway. HCV may also avoid autophagy by preventing itself from being recognized by autophagy machinery. Immuno-electron microscopy and immunofluoresence results showed that there is no-or rare co-localization of HCV proteins with the autophagic vacuoles (47) . Therefore, HCV hides from being recognized by the host cells' defenses. HCV, following its cell entrance, uses the host cell factors to help in its replication. It has been experimentally proven that HCV uses autophagy related proteins such as Beclin 1, Atg4B, Atg5 and Atg12 for the translation of the viral mRNA thereby initiating its replication. Once the replication is initiated, HCV can multiply itself and enhance the infection (64) . It was reported that the viral non-structural protein NSP5B, the viral RNAdependent RNA polymerase, interacts with host proteins required for autophagy induction (6), and Ke and colleagues presented data that suggest UPR induction and formation of autophagic vacuoles was induced by HCV replication (34) . HCV infection activates three main arms in UPR including ATF6, IRE1, and PERK, which induces CHOP expression (a UPR-dependent transcriptional factor) (Fig. 5) . Knocking down of CHOP or inhibiting each of the UPR arms inhibits autophagy in HCV-infected cells which highlights the importance of UPR in HCV-induced autophagy (65) . This evidence emphasizes the role of autophagy-and UPR-related genes in HCV replication.
Chloroquine, which is an inhibitor of autophagic proteolysis, also inhibits HCV replication in liver cells (66). Treatment with chloroquine down-regulates HCV replication in a dose dependent manner, indicating that autophagy-proteolysis plays an important role in viral replication. These experimental results highlight the fact that autophagic proteolysis can be a target for the treatment of viral hepatitis. Apart from that, this report suggests that chloroquine can be used as a drug for the treatment of chronic hepatitis C (66). The recent report by Shrivatsava et al demonstrates that the knockdown of autophagy related proteins, Beclin 1 or autophagy related protein 7 (Atg7) in immortalized human hepatocytes infected with HCV, enhances the interferon signaling pathways and induces apoptosis. However, the activation of interferon signaling pathway and apoptosis are absent in infected control immortalized human hepatocytes. These experimental evidences also show that HCV induced autophagy impairs innate immunity (67) . HBV regulates and "hires" autophagy for its benefit to promote replication. A recent report shows that HBV can enhance the autophagic process in hepatoma cells without promoting the degradation of lysosomes (28) . This report also demonstrates by mutational analysis that HBV small surface proteins (HBsAg) are required to induce autophagy. Transfection of HBsAg is sufficient enough to induce autophagy in hepatoma cells. Autophagy machinery is activated during HBV infection and is responsible for enhancement of HBV replication in the cells (28) . Another experimental finding shows that HBV transfected into the hepatoma cells induces an early autophagic response without increasing the autophagic protein degradation (27) . This autophagic response enhances viral replication through the binding of HBV X protein (HBx) to PI3KC3. These experimental studies provide evidence that the autophagy pathway can be used as a target for the treatment of patients with HBV infection (26, 27) . In the report published by Tang and colleagues (26) , HBVx protein when transfected into the hepatocytes, leads to the increased activity of Beclin 1 protein expression, which in turn leads to the enhancement of autophagy. These results certainly provide evidence that HBV can induce autophagy in hepatocytes and thereby using this process for enhancing its replication. In conclusion, the autophagy pathway can be a target for designing drugs that better serve the purpose of patients with HBV infections in the liver. The role of autophagy in HBV infection is summarized in Figure 4 .
Conclusion and Future Direction
Tremendous progress in research on liver pathology in recent years allowed for characterization of diverse forms of hepatitis. Hepatitis is usually induced by infection by different pathogens and routes. Recent discoveries suggest several preventive strategies, including vaccines and passive immunization approaches, will be useful Since HBV and HCV specifically modulate autophagy in host cells to enhance virion production (as described previously), targeting different steps of autophagy that modulate HBV and HCV replication and life cycle opens the way for the development of novel therapeutic strategies for these diseases. Autophagy is tightly linked to other cell death pathways involving apoptosis, necrosis, and ER-stress induced cell death.
Therefore, targeting autophagy to direct the infected host cells being killed by other cell death mechanism could yield another strategy to combat HBV and HCV infection.
Research and development of new anti-HBV and -HCV drugs is also hampered by the lack of good in vitro models of HBV-and HCV infection as well as lack of understanding of docking mechanisms used by these viruses to enter hepatocytes. 
